Browsing Tag

CytoReason

CytoReason to License Its IBD Disease Model to Sanofi in Expanded Multiyear,…

Dustin Moskovitz Jan 23, 2023 0

TEL AVIV, Israel, Jan. 23, 2023 (GLOBE NEWSWIRE) -- CytoReason, a leader and pioneer in computational disease modeling, today announced an expansion of its collaboration with Sanofi. The…

Business

Pfizer extends collaboration with disease model co CytoReason

Dustin Moskovitz Sep 20, 2022 0

Israeli company CytoReason, a developer of computational disease models that assist in the design of drugs by the pharmaceuticals industry, has announced the extension of…